Andere Sprachen Revvity, Inc.

Aktien

850943

US7140461093

RVTY

Medizinische Ausrüstung

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 12.12.2025			% 5 Tage	Veränd. 1. Jan.
100,49 ^USD	-3,30 %		-0,30 %	-9,96 %

02.12.	Revvity, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 09:00 AM
18.11.	Revvity, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 02:00 PM

Andere Sprachen

Sector Update: Health Care Stocks Mixed Premarket Monday	10.11.
Revvity Enters Definitive Agreement to Acquire ACD/Labs	10.11.
Revvity Seeks Acquisitions	10.11.
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities	10.11.
Tranche Update on Revvity, Inc.'s Equity Buyback Plan announced on November 4, 2024.	04.11.
Revvity to Present at Upcoming Investor Conferences	28.10.
Revvity : Third Quarter 2025 Transcript	28.10.
The new silk road of optimism	27.10.
Sector Update: Health Care Stocks Mixed Premarket Monday	27.10.
Revvity : Q3 2025 Revvity Earnings Conference Call Presentation	27.10.
Revvity, Inc. authorizes a Buyback Plan.	27.10.
Revvity, Inc.'s Equity Buyback announced on November 4, 2024, has expired with 8,503,054 shares, representing 7.15% for $839.16 million.	27.10.
Revvity, Inc. announces an Equity Buyback for $1,000 million worth of its shares.	27.10.
Revvity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 28, 2025	27.10.
Stocks Gain Pre-Bell as US-China Trade Deal Hopes Rise; Investors Await Fed Policy Decision, Big Tech Earnings	27.10.
Revvity, Inc. Revises Earnings Guidance for the Full Year Ending December 28, 2025	27.10.
Revvity lifts profit forecast on renewed demand in diagnostics unit	27.10.
Revvity Q3 Adjusted Earnings Fall, Revenue Rises; 2025 EPS Guidance Lifted -- Shares Down Pre-Bell	27.10.
Earnings Flash (RVTY) Revvity, Inc. Reports Q3 Revenue $698.9M, vs. FactSet Est of $699.4M	27.10.
(RVTY) Revvity Expects 2025 Revenue Range $2.83B-$2.88B, vs. FactSet Est of $2.85B	27.10.
Earnings Flash (RVTY) Revvity, Inc. Posts Q3 Adjusted EPS $1.18 per Share, vs. FactSet Est of $1.14	27.10.
(RVTY) Revvity Expects 2025 Adjusted EPS Range $4.90 to $5.00, vs. FactSet Est of $4.86	27.10.
Earnings Flash (RVTY) Revvity Posts Fiscal Q3 Revenue $698.9M, vs. FactSet Est of $699.4M	27.10.
Earnings Flash (RVTY) Revvity Posts Fiscal Q3 Adjusted EPS $1.18, vs. FactSet Est of $1.14	27.10.
Health tech firm Revvity misses Q3 revenue estimates, announces $1 bln buyback program	27.10.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Revvity, Inc.

Aktien

850943

US7140461093

RVTY

Medizinische Ausrüstung

Andere Sprachen

Filter